Future studies are necessary to determine if the concomitant genetic and epigenetic MLH1 inactivation is more frequent in EC in comparison with CRC and to understand if high levels of tumor MLH1 promoter methylation may represent a real and useful marker of an underlying germline MLH1 methylation. Here, MLH1 is linked to colorectal carcinoma.